News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
518 Results
Type
Article (18)
Company Profile (1)
Press Release (499)
Section
Business (122)
Deals (18)
Drug Development (109)
FDA (6)
Job Trends (2)
News (250)
Policy (22)
Tag
Academia (2)
Alliances (26)
Approvals (6)
Best Places to Work (1)
Cancer (11)
Cell therapy (1)
Clinical research (102)
COVID-19 (2)
Data (9)
Earnings (61)
Events (91)
FDA (7)
Government (2)
Healthcare (4)
Infectious disease (2)
Intellectual property (1)
IPO (16)
Job creations (1)
Legal (1)
Lymphoma (11)
Manufacturing (1)
Mergers & acquisitions (2)
NextGen: Class of 2026 (1)
Patents (1)
People (44)
Pharmaceutical (1)
Phase 1 (19)
Phase 2 (42)
Phase 3 (46)
Pipeline (5)
Postmarket research (2)
Preclinical (9)
Rare diseases (9)
Regulatory (23)
Research institute (2)
Vaccines (1)
Date
Last 365 days (23)
2025 (29)
2024 (35)
2023 (29)
2022 (35)
2021 (42)
2020 (34)
2019 (46)
2018 (29)
2017 (27)
2016 (37)
2015 (39)
2014 (34)
2013 (35)
2012 (24)
2011 (18)
2010 (18)
Location
Asia (5)
Europe (7)
Massachusetts (1)
New Jersey (39)
New York (3)
United States (42)
518 Results for "soligenix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
December 8, 2025
·
7 min read
Press Releases
Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results
November 10, 2025
·
9 min read
Press Releases
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
December 4, 2025
·
7 min read
Press Releases
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
December 18, 2025
·
14 min read
Press Releases
Soligenix Announces Closing of $7.5 Million Public Offering
September 29, 2025
·
7 min read
Press Releases
Soligenix Announces Pricing of $7.5 Million Public Offering
September 29, 2025
·
7 min read
Press Releases
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
October 15, 2025
·
18 min read
Press Releases
Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
November 20, 2025
·
17 min read
Press Releases
Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
October 1, 2025
·
18 min read
Press Releases
Soligenix Announces Recent Accomplishments And Second Quarter 2025 Financial Results
August 15, 2025
·
9 min read
1 of 52
Next
